TLcom Capital

TLcom Capital is one of the veteran multi-stage African venture firms, with a Nairobi-anchored team and a portfolio that spans Andela, uLesson, Pula, Autochek, and Ilara Health. The firm invests across pre-seed, seed, Series A, and Series B with checks ranging from roughly $500K at seed to $10M at later stages, which gives it the flexibility to lead first institutional rounds and to follow on meaningfully into companies it has conviction in. Within healthcare, TLcom led the Series A in Ilara Health, the Kenyan diagnostics-for-clinics platform that has now expanded across East Africa, and that investment is a useful illustration of the firm’s thesis: tech-enabled business models that solve complex local problems where the AI or software is in service of a real-world distribution and operations challenge. The geographic advantage is genuine. The TLcom team has on-the-ground partners across Lagos, Nairobi, and Cairo, with deep relationships across the African operator and policy ecosystem that few competing funds can match. For a healthtech founder building in Sub-Saharan Africa, having TLcom on the cap table opens doors with regional regulators, payers, hospital groups, and downstream development-finance investors. The right founder profile is a team with strong local operating instincts, building infrastructure or services that materially expand access to healthcare in African markets, with a believable path to multi-country scale and venture-grade returns. The wrong fit is a Western-market-first company that lists Africa as an aspirational expansion plan; TLcom invests in Africa as the primary market, not as a side bet. The right entry path is through warm introductions from existing TLcom portfolio CEOs, from co-investors like Novastar, Partech Africa, and DOB Equity, or from the African Business Angels Network and similar operator communities. When pitching, lead with the local market insight and the unit economics that work in African price points and infrastructure realities, then layer the AI or diagnostics technology story on top. Caveats: TLcom is a generalist Africa fund rather than a healthcare specialist, so founders should expect strong commercial and capital-markets diligence but lighter clinical-domain scrutiny, and clinical-specialist co-investors will likely be welcomed onto the cap table. Treat TLcom as the anchor pan-African partner that gives your healthtech company credibility on the continent and access to the next round.